Parkinson Disease
Conditions
Brief summary
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Interventions
None listed
Sponsors
Boehringer Ingelheim
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
Observation Criteria: Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample. Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator. Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| The occurrence of a past (since onset of PD) ICD | 6 months |
| Demographic and medical history measures | up to 14 days after Visit 1 |
| Scores on psychiatric/neuropsychological instruments/tests | up to 14 days after Visit 1 |
Countries
Canada, United States
Outcome results
None listed